Meghan Scanlon - Feb 15, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP,Pres,Urology Pelvic Health
Signature
/s/ Vance R. Brown, Attorney-in-fact
Stock symbol
BSX
Transactions as of
Feb 15, 2022
Transactions value $
-$17,076
Form type
4
Date filed
2/17/2022, 07:37 PM
Previous filing
Aug 4, 2021
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +1.11K +5.79% $0.00 20.3K Feb 15, 2022 Direct F1
transaction BSX Common Stock Tax liability -$17.1K -388 -1.92% $44.01 19.9K Feb 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -1.11K -50% $0.00 1.11K Feb 15, 2022 Common Stock 1.11K Direct F1, F2
transaction BSX Restricted Stock Units Award $0 +8.49K $0.00 8.49K Feb 16, 2022 Common Stock 8.49K Direct F3, F4
transaction BSX Stock Option (Right to Buy) Award $0 +24.3K $0.00 24.3K Feb 16, 2022 Common Stock 24.3K $44.19 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F3 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F5 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

Remarks:

scanlonpoa.txt